Literature DB >> 18365759

Lymphoma survival patterns by WHO subtype in the United States, 1973-2003.

Xuesong Han1, Briseis Kilfoy, Tongzhang Zheng, Theodore R Holford, Cairong Zhu, Yong Zhu, Yawei Zhang.   

Abstract

With the incidence and prevalence of lymphoid neoplasms increasing, a comparison of survival patterns by subtype may provide critical clues for improving the disease burden. We conducted a comprehensive survival analysis for 254,702 lymphoid neoplasm cases diagnosed during 1973-2003 at 17 Surveillance, Epidemiology and End Results (SEER) registries according to the World Health Organization (WHO) classification introduced in 2001. The best survival was observed for Hodgkin lymphoma among young patients, and the worst survival was observed among cases with plasma cell neoplasms, particularly plasma cell leukemia, in all racial groups. Being diagnosed at a lower stage without B-symptoms and a non-HIV/AIDS status favored survival for each type of lymphoma. Males typically had lower survival rates than females, but the opposite was observed for Burkitt lymphoma/leukemia among non-whites and multiple myeloma among non-Hispanic whites. Non-Hispanic whites typically had higher survival rates than blacks with the exception of multiple myeloma. Survival rates decline with age at diagnosis among elders, while the patterns were diverse by subtype among younger cases. The differences in lymphoma survival patterns suggest that distinct prognostic risk factors impact survival by subtype and that future research and public health interventions should address racial disparities in lymphoma survivorship.

Entities:  

Mesh:

Year:  2008        PMID: 18365759     DOI: 10.1007/s10552-008-9147-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  31 in total

1.  The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.

Authors:  Rebecca L Boddicker; N Sertac Kip; Xiaoming Xing; Yu Zeng; Zhi-Zhang Yang; Jeong-Heon Lee; Luciana L Almada; Sherine F Elsawa; Ryan A Knudson; Mark E Law; Rhett P Ketterling; Julie M Cunningham; Yanhong Wu; Matthew J Maurer; Megan M O'Byrne; James R Cerhan; Susan L Slager; Brian K Link; Julie C Porcher; Deanna M Grote; Diane F Jelinek; Ahmet Dogan; Stephen M Ansell; Martin E Fernandez-Zapico; Andrew L Feldman
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

2.  Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival.

Authors:  Xuesong Han; Tongzhang Zheng; Francine M Foss; Qing Lan; Theodore R Holford; Nathaniel Rothman; Shuangge Ma; Yawei Zhang
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

3.  Dietary nitrate and nitrite intake and non-Hodgkin lymphoma survival.

Authors:  Briseis Aschebrook-Kilfoy; Mary H Ward; Tongzhang Zheng; Theodore R Holford; Peter Boyle; Brian Leaderer; Yawei Zhang
Journal:  Nutr Cancer       Date:  2012-03-16       Impact factor: 2.900

4.  Orthopaedic case of the month: A 62-year-old woman with neck pain and neurologic findings.

Authors:  Dean Papaliodis; Timothy Roberts; Matthew DiCaprio; James Lawrence
Journal:  Clin Orthop Relat Res       Date:  2013-05-11       Impact factor: 4.176

Review 5.  Extramedullary B lymphoblastic leukemia/lymphoma (B-ALL/B-LBL): a diagnostic challenge.

Authors:  Praveen Ramakrishnan Geethakumari; Marc S Hoffmann; Naveen Pemmaraju; Shimin Hu; Jeffrey L Jorgensen; Susan O'Brien; Naval Daver
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-02-02

6.  Polymorphisms in immune function genes and non-Hodgkin lymphoma survival.

Authors:  Briseis Aschebrook-Kilfoy; Tongzhang Zheng; Francine Foss; Shuangge Ma; Xuesong Han; Qing Lan; Theodore Holford; Yingtai Chen; Brian Leaderer; Nathaniel Rothman; Yawei Zhang
Journal:  J Cancer Surviv       Date:  2011-11-24       Impact factor: 4.442

7.  Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era.

Authors:  Grzegorz S Nowakowski; Matthew J Maurer; Thomas M Habermann; Stephen M Ansell; William R Macon; Kay M Ristow; Cristine Allmer; Susan L Slager; Thomas E Witzig; James R Cerhan
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

8.  Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010.

Authors:  Hermann Brenner; Adam Gondos; Dianne Pulte
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

9.  Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use.

Authors:  Sarah J Lowry; Jessica Chubak; Oliver W Press; Barbara McKnight; Noel S Weiss
Journal:  Ann Epidemiol       Date:  2013-06       Impact factor: 3.797

Review 10.  Primary Plasma Cell Leukemia: Identity Card 2016.

Authors:  Pellegrino Musto; Vittorio Simeon; Katia Todoerti; Antonino Neri
Journal:  Curr Treat Options Oncol       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.